Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up.
We report a case of a woman who showed hepatic and renal AA amyloidosis with a liver adenoma associated with the use of oral contraceptives. A nephrotic syndrome secondary to the renal amyloidosis underwent complete remission 7 years after the withdrawal of oral contraceptive therapy. Twenty-nine months after the initial presentation, the patient was admitted with acute upper abdominal pain and abdominal tenderness. The abdominal ultrasound revealed a subphrenic fluid collection, and a presumptive diagnosis of a ruptured hepatic adenoma was made. The liver adenoma diminished from 8 cm to 1 cm over a 13-year follow up after the discontinuance of oral contraceptive therapy.
Cosme
A
A
Service of Gastroenterology, Hospital Nuestra Señora de Aránzazu, San Sebastián, Spain.
Horcajada
J P
JP
Vidaur
F
F
Ojeda
E
E
Torrado
J
J
Arenas
J I
JI
D018248:Adenoma, Liver Cell / Q000150:complications* / Q000175:diagnosis; D000328:Adult; D000686:Amyloidosis / Q000139:chemically induced* / Q000175:diagnosis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis
D003276:Contraceptives, Oral